FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Masoud Azodi

Research Profile

Disorders

Anatomy

Tumor Cell Line

Concepts & Ideas

Procedures

Physiology

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Michelle A Glasgow; Thomas J Rutherford; Alessandro D Santin; Dan-Arin Silasi; Herbert Yu; Masoud Azodi; Peter E Schwartz
Neoadjuvant chemotherapy (NACT) is an effective way of managing elderly women with advanced stage ovarian cancer (FIGO Stage IIIC and IV).
Shabnam Kashani; Anita Sargent; Dan-Arin Silasi; Karim Elsahwi; Taryn Gallo; Masoud Azodi
Vaginal cuff dehiscence in robotic-assisted total hysterectomy.
Taryn Gallo; Shabnam Kashani; Divya A Patel; Dan-Arin Silasi; Karim Elsahwi; Masoud Azodi
Robotic-assisted laparoscopic hysterectomy: outcomes in obese and morbidly obese patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Masoud Azodi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Michelle A Glasgow; Thomas J Rutherford; Alessandro D Santin; Dan-Arin Silasi; Herbert Yu; Masoud Azodi; Peter E Schwartz
Neoadjuvant chemotherapy (NACT) is an effective way of managing elderly women with advanced stage ovarian cancer (FIGO Stage IIIC and IV).
Journal of surgical oncology 2013;107(2):195-200.
2012: Shabnam Kashani; Anita Sargent; Dan-Arin Silasi; Karim Elsahwi; Taryn Gallo; Masoud Azodi
Vaginal cuff dehiscence in robotic-assisted total hysterectomy.
JSLS : Journal of the Society of Laparoendoscopic Surgeons / Society of Laparoendoscopic Surgeons 2012;16(4):530-6.
2012: Taryn Gallo; Shabnam Kashani; Divya A Patel; Dan-Arin Silasi; Karim Elsahwi; Masoud Azodi
Robotic-assisted laparoscopic hysterectomy: outcomes in obese and morbidly obese patients.
JSLS : Journal of the Society of Laparoendoscopic Surgeons / Society of Laparoendoscopic Surgeons 2012;16(3):421-7.
2012: Stefania Bellone; I Bortolomai; N Buza; E Cocco; S Gasparrini; Sergio Pecorelli; E Ratner; D Roque; Thomas Rutherford; M Abu-Khalaf; Masoud Azodi; Peter E Schwartz; Dan-Arin Silasi; Alessandro D Santin
Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapy.
British journal of cancer 2012;106(9):1543-50.
2012: Karim S El-Sahwi; Jessica L Illuzzi; Elena S Ratner; Thomas J Rutherford; Masoud Azodi; Nina Carusillo; Peter E Schwartz; Dan-Arin Silasi; Joyce Varughese; Alessandro D Santin
A survey of gynecologic oncologists regarding the end-of-life discussion: a pilot study.
Gynecologic oncology 2012;124(3):471-3.
2012: Karim S ElSahwi; Taryn N Gallo; Charlene Hooper; Elena Ratner; Thomas J Rutherford; Alessandro D Santin; Peter E Schwartz; Dan-Arin Silasi; Maria C De Leon; Masoud Azodi
Comparison between 155 cases of robotic vs. 150 cases of open surgical staging for endometrial cancer.
Gynecologic oncology 2012;124(2):260-4.
2011: Francesca Casagrande; Emiliano Cocco; Sergio Pecorelli; Christine E Richter; Thomas J Rutherford; Dan Arin-Silasi; Masoud Azodi; Marta Bellone; Stefania Bellone; Peter E Schwartz; Eric Siegel; Paola Todeschini; Joyce Varughese; Alessandro D Santin
Eradication of chemotherapy-resistant CD44+ human ovarian cancer stem cells in mice by intraperitoneal administration of Clostridium perfringens enterotoxin.
Cancer 2011;117(24):5519-28.
2011: Karim S Elsahwi; Jessica L Illuzzi; Elena Ratner; Masoud Azodi; Emma Barber; Natalia Buza; Alessandro D Santin; Peter E Schwartz; Dan-Arin Silasi; Thomas J Rutherford
The significance of perineural invasion in early-stage cervical cancer.
Gynecologic oncology 2011;123(3):561-4.
2011: Joyce Varughese; Peter E Schwartz; Dan-Arin Silasi; Masoud Azodi; Stefania Bellone; Natalia Buza; Emiliano Cocco; Sergio Pecorelli; Elena Ratner; Thomas J Rutherford; Alessandro D Santin
Cervical carcinomas overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody.
American journal of obstetrics and gynecology 2011;205(6):567.e1-7.
2011: P Todeschini; J Varughese; Peter E Schwartz; Dan-Arin Silasi; Masoud Azodi; Stefania Bellone; N Buza; L Carrara; E Cocco; F Guzzo; Pei Hui; K Lin; Sergio Pecorelli; E Ratner; Thomas Rutherford; Alessandro D Santin
Her2/neu extracellular domain shedding in uterine serous carcinoma: implications for immunotherapy with trastuzumab.
British journal of cancer 2011;105(8):1176-82.
2011: Emiliano Cocco; Ken-Yu Lin; Charles J Lockwood; Sergio Pecorelli; Thomas J Rutherford; Masoud Azodi; Marta Bellone; Stefania Bellone; Natalia Buza; Luisa Carrara; Peter E Schwartz; Dan-Arin Silasi; Renata Tassi; Paola Todeschini; Joyce Varughese; Alessandro D Santin
Tissue factor expression in ovarian cancer: implications for immunotherapy with hI-con1, a factor VII-IgGF(c) chimeric protein targeting tissue factor.
Clinical & experimental metastasis 2011;28(7):689-700.
2011: Steven J Skates; Patrick M Sluss; Linda Van Le; Phuong Mai; Susan G Nayfield; Stacy Nerenstone; William Newland; Marion Piedmonte; Gustavo C Rodriguez; John O Schorge; Deborah K Armstrong; Masoud Azodi; Mack Barnes; Andrew Berchuck; Wendy Brewster; Saundra S Buys; David E Cohn; Mary B Daly; Susan A Davidson; Susan M Domchek; Charles W Drescher; Carol J Fabian; Dianne M Finkelstein; Mark H Greene; Nora K Horick; Ira R Horowitz; Claudine Isaacs; Carol H Kasten; Noah D Kauff; Karen Lu
Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal status.
Cancer prevention research (Philadelphia, Pa.) 2011;4(9):1401-8.
2011: Eugene P Toy; Ho-Hyung Woo; Masoud Azodi; Tiffany Lamb; William J Roy; Setsuko K Chambers
Inhibition of the c-fms proto-oncogene autocrine loop and tumor phenotype in glucocorticoid stimulated human breast carcinoma cells.
Breast cancer research and treatment 2011;129(2):411-9.
2011: Michael G Kelly; Gil Mor; Alan Husband; David M O'Malley; Lisa Baker; Masoud Azodi; Peter E Schwartz; Thomas J Rutherford
Phase II evaluation of phenoxodiol in combination with cisplatin or paclitaxel in women with platinum/taxane-refractory/resistant epithelial ovarian, fallopian tube, or primary peritoneal cancers.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2011;21(4):633-9.
2011: Rhoda Raji; Elena Ratner; Thomas J Rutherford; Peter Schwartz; Dan-Arin Silasi; Paola Todeschini; Joyce Varughese; Masoud Azodi; Stefania Bellone; Marta Betti; Natalia Buza; Luisa Carrara; Emiliano Cocco; Sara Gasparrini; Federica Guzzo; Sergio Pecorelli; Alessandro D Santin
Uterine and ovarian carcinosarcomas overexpressing Trop-2 are sensitive to hRS7, a humanized anti-Trop-2 antibody.
Journal of experimental & clinical cancer research : CR 2011;30():106.
2011: Emiliano Cocco; Michelle Glasgow; Charles J Lockwood; Sergio Pecorelli; Thomas J Rutherford; Masoud Azodi; Marta Bellone; Stefania Bellone; Natalia Buza; Luisa Carrara; Peter E Schwartz; Dan-Arin Silasi; Paola Todeschini; Joyce Varughese; Alessandro D Santin
Expression of tissue factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix: implications for immunotherapy with hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor.
BMC cancer 2011;11():263.
2010: Christine E Richter; Emiliano Cocco; Stefania Bellone; Marta Bellone; Francesca Casagrande; Paola Todeschini; Dominik Rüttinger; Dan-Arin Silasi; Masoud Azodi; Peter E Schwartz; Thomas J Rutherford; Sergio Pecorelli; Alessandro D Santin
Primary cervical carcinoma cell lines overexpress epithelial cell adhesion molecule (EpCAM) and are highly sensitive to immunotherapy with MT201, a fully human monoclonal anti-EpCAM antibody.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2010;20(9):1440-7.
2010: Christine E Richter; Emiliano Cocco; Stefania Bellone; Dan-Arin Silasi; Dominik Rüttinger; Masoud Azodi; Peter E Schwartz; Thomas J Rutherford; Sergio Pecorelli; Alessandro D Santin
High-grade, chemotherapy-resistant ovarian carcinomas overexpress epithelial cell adhesion molecule (EpCAM) and are highly sensitive to immunotherapy with MT201, a fully human monoclonal anti-EpCAM antibody.
American journal of obstetrics and gynecology 2010;203(6):582.e1-7.
2010: E Cocco; Z Hu; C E Richter; Stefania Bellone; F Casagrande; M Bellone; P Todeschini; G Krikun; Dan-Arin Silasi; Masoud Azodi; Peter E Schwartz; Thomas Rutherford; N Buza; Sergio Pecorelli; C J Lockwood; Alessandro D Santin
hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor for immunotherapy of uterine serous papillary carcinoma.
British journal of cancer 2010;103(6):812-9.
2010: Christine E Richter; Pei Hui; Natalia Buza; Dan-Arin Silasi; Masoud Azodi; Alessandro D Santin; Peter E Schwartz; Thomas Rutherford
HER-2/NEU overexpression in vulvar Paget disease: the Yale experience.
Journal of clinical pathology 2010;63(6):544-7.
2010: Oluwole Fadare; Amanda Bonvicino; Maritza Martel; Idris L Renshaw; Masoud Azodi; Vinita Parkash
Pleomorphic rhabdomyosarcoma of the uterine corpus: a clinicopathologic study of 4 cases and a review of the literature.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2010;29(2):122-34.
2010: K El-Sahwi; Stefania Bellone; E Cocco; M Cargnelutti; F Casagrande; M Bellone; M Abu-Khalaf; N Buza; Fattaneh A Tavassoli; Pei Hui; Dan-Arin Silasi; Masoud Azodi; Peter E Schwartz; Thomas Rutherford; Sergio Pecorelli; Alessandro D Santin
In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma.
British journal of cancer 2010;102(1):134-43.
2010: Karim El-Sahwi; Stefania Bellone; Emiliano Cocco; Francesca Casagrande; Marta Bellone; Maysa Abu-Khalaf; Natalia Buza; Fattaneh A Tavassoli; Pei Hui; Dominik Rüttinger; Dan-Arin Silasi; Masoud Azodi; Peter E Schwartz; Thomas Rutherford; Sergio Pecorelli; Alessandro D Santin
Overexpression of EpCAM in uterine serous papillary carcinoma: implications for EpCAM-specific immunotherapy with human monoclonal antibody adecatumumab (MT201).
Molecular cancer therapeutics 2010;9(1):57-66.
2009: Orkun Tan; Edward Luchansky; Stephen Rosenman; Tarah Pua; Masoud Azodi
Peritoneal tuberculosis with elevated serum Ca-125 level mimicking advanced stage ovarian cancer: a case report.
Archives of gynecology and obstetrics 2009;280(2):333-5.
2009: E Cocco; Stefania Bellone; K El-Sahwi; M Cargnelutti; F Casagrande; N Buza; Fattaneh A Tavassoli; Eric Siegel; Irene Visintin; E Ratner; Dan-Arin Silasi; Masoud Azodi; Peter E Schwartz; Thomas Rutherford; Sergio Pecorelli; Alessandro D Santin
Serum amyloid A (SAA): a novel biomarker for uterine serous papillary cancer.
British journal of cancer 2009;101(2):335-41.
2009: Stefania Bellone; Eric Siegel; Emiliano Cocco; Marilisa Cargnelutti; Dan-Arin Silasi; Masoud Azodi; Peter E Schwartz; Thomas Rutherford; Sergio Pecorelli; Alessandro D Santin
Overexpression of epithelial cell adhesion molecule in primary, metastatic, and recurrent/chemotherapy-resistant epithelial ovarian cancer: implications for epithelial cell adhesion molecule-specific immunotherapy.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2009;19(5):860-6.
2009: Elena S Ratner; Eugene Toy; David M O'Malley; Jessica N McAlpine; Thomas Rutherford; Masoud Azodi; Susan A Higgins; Peter E Schwartz
Brain metastases in epithelial ovarian and primary peritoneal carcinoma.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2009;19(5):856-9.
2009: Christine E Richter; Biyun Qian; Maritza Martel; Herbert Yu; Masoud Azodi; Thomas Rutherford; Peter E Schwartz
Ovarian preservation and staging in reproductive-age endometrial cancer patients.
Gynecologic oncology 2009;114(1):99-104.
2009: Stefania Bellone; Karim El-Sahwi; Emiliano Cocco; Francesca Casagrande; Marilisa Cargnelutti; Michela Palmieri; Eliana Bignotti; Chiara Romani; Dan-Arin Silasi; Masoud Azodi; Peter E Schwartz; Thomas J Rutherford; Sergio Pecorelli; Alessandro D Santin
Human papillomavirus type 16 (HPV-16) virus-like particle L1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines.
Journal of virology 2009;83(13):6779-89.
2009: Stefania Bellone; Simone Anfossi; Timothy J O'Brien; Martin J Cannon; Dan-Arin Silasi; Masoud Azodi; Peter E Schwartz; Thomas Rutherford; Sergio Pecorelli; Alessandro D Santin
Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer.
Cancer 2009;115(4):800-11.
2009: Eugene P Toy; Masoud Azodi; Nancy L Folk; Christina M Zito; Caroline J Zeiss; Setsuko K Chambers
Enhanced ovarian cancer tumorigenesis and metastasis by the macrophage colony-stimulating factor.
Neoplasia (New York, N.Y.) 2009;11(2):136-44.
2009: Stefania Bellone; Simone Anfossi; Timothy J O'Brien; Martin J Cannon; Dan-Arin Silasi; Masoud Azodi; Peter E Schwartz; Thomas Rutherford; Sergio Pecorelli; Alessandro D Santin
Generation of CA125-specific cytotoxic T lymphocytes in human leukocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer.
American journal of obstetrics and gynecology 2009;200(1):75.e1-10.
2008: Alireza Abidi; Kirsten Menn; Andrea Sherman; Thomas Konia; Masoud Azodi
Cervical carcinosarcoma: a case report.
The Journal of reproductive medicine 2008;53(2):138-40.
2008: Dan-Arin Silasi; Jessica L Illuzzi; Michael G Kelly; Thomas Rutherford; Gil Mor; Masoud Azodi; Peter E Schwartz
Carcinosarcoma of the ovary.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2008;18(1):22-9.
2007: June Hou; Michael G Kelly; Herbert Yu; Jessica N McAlpine; Masoud Azodi; Thomas Rutherford; Peter E Schwartz
Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease.
Gynecologic oncology 2007;105(1):211-7.
2006: Dan-Arin Silasi; Ayesha B Alvero; Jessica Illuzzi; Michael Kelly; Rui Chen; Han-Hsuan Fu; Peter Schwartz; Thomas Rutherford; Masoud Azodi; Gil Mor
MyD88 predicts chemoresistance to paclitaxel in epithelial ovarian cancer.
The Yale journal of biology and medicine 2006;79(3-4):153-63.
2006: Jessica N McAlpine; Michael G Kelly; David M O'Malley; Masoud Azodi; Karen Coombe; Peter E Schwartz; Thomas Rutherford
Atypical presentations of carboplatin hypersensitivity reactions: characterization and management in patients with gynecologic malignancies.
Gynecologic oncology 2006;103(1):288-92.
2005: Shlomo A Koyfman; Alireza Abidi; Pars Ravichandran; Susan A Higgins; Masoud Azodi
Adenoid cystic carcinoma of the cervix.
Gynecologic oncology 2005;99(2):477-80.
2005: Michael G Kelly; David M O'Malley; Pei Hui; Jessica N McAlpine; Herbert Yu; Thomas Rutherford; Masoud Azodi; Peter E Schwartz
Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy.
Gynecologic oncology 2005;98(3):353-9.
2005: David M O'Malley; Masoud Azodi; Anita Makkenchery; Jacob Tangir; Jessica N McAlpine; Michael Kelly; Peter Schwartz; Thomas Rutherford
Weekly topotecan in heavily pretreated patients with recurrent epithelial ovarian carcinoma.
Gynecologic oncology 2005;98(2):242-8.
2005: Nathalie Bonafe; Maureen Gilmore-Hebert; Nancy L Folk; Masoud Azodi; Yi Zhou; Setsuko K Chambers
Glyceraldehyde-3-phosphate dehydrogenase binds to the AU-Rich 3' untranslated region of colony-stimulating factor-1 (CSF-1) messenger RNA in human ovarian cancer cells: possible role in CSF-1 posttranscriptional regulation and tumor phenotype.
Cancer research 2005;65(9):3762-71.
2005: Jessica N McAlpine; Masoud Azodi; David M O'Malley; Michael Kelly; G Golenewsky; M Martel; Thomas Rutherford; Fattaneh A Tavassoli
Extrarenal Wilms' tumor of the uterine corpus.
Gynecologic oncology 2005;96(3):892-6.
2004: Michael G Kelly; David M O'Malley; Pei Hui; Jessica N McAlpine; J Dziura; Thomas Rutherford; Masoud Azodi; Setsuko K Chambers; Peter E Schwartz
Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation.
Gynecologic oncology 2004;95(3):469-73.
1999: Masoud Azodi; Setsuko K Chambers; Thomas Rutherford; Ernest I Kohorn; Peter E Schwartz; Joseph T Chambers
Adenocarcinoma in situ of the cervix: management and outcome.
Gynecologic oncology 1999;73(3):348-53.
1999: J B Johns; K O Odunsi; S Fleischman; Masoud Azodi; Peter E Schwartz
Serous adenocarcinoma of the uterus presenting as paraneoplastic cerebellar degeneration.
Gynecologic oncology 1999;73(2):326-30.